DG: Anti-malaria drug may have reduced Covid-19 patients’ need for ICU

Annabelle Lee

Modified 7 Apr 2020, 2:45 pm

UPDATED 10.40PM | CORONAVIRUS | Malaysia’s use of an antimalarial drug appears to have prevented Covid-19 from worsening and thus contributed to fewer patients in the ICU.

Health Ministry director-general Dr Noor Hisham Abdullah said today that hospitals have been administering hydroxychloroquine on an off-label basis since the outbreak began...

All Access Plan
starting from


per month
Subscribe Now
You can cancel anytime.
Get unlimited access to our articles on web and apps
Add comments to our articles
Bookmark articles to read later
We accept
Student or Senior Citizen? Get a special rateGroup / Institutional / Corporate Plans
Already Subscribed?
Sign In

Share this story